Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials recall — FDA D-0285-2025
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Overview of recall records associated with Amgen, Inc., including dates, categories and classifications where available.
Classification mix: Class II: 2.
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
This page summarizes recall records in which the official source identifies Amgen, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.